Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
10/20/1992 | US5157112 Antibodies immunoreactive with the T-cell growth factor, P40 |
10/20/1992 | US5157104 Antitumor, anticarcinogenic agents |
10/20/1992 | US5157020 Two covalently bonded peptides |
10/20/1992 | US5156977 Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use |
10/20/1992 | US5156959 Introducing recombinant DNA construction into gramnegative bacteria, cultivating, recovering secreted proteins |
10/20/1992 | CA2064933A1 Carrier protein |
10/16/1992 | WO1992018148A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof |
10/16/1992 | CA2108467A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof |
10/15/1992 | WO1992017500A1 Novel megakaryocyte amplifying factor and production thereof |
10/15/1992 | WO1992017498A1 Product and method for improving keratinocyte adhesion to the dermis |
10/15/1992 | WO1992017497A1 Human pf4a receptors and their use |
10/15/1992 | WO1992017495A1 Antibiotic a 40926 ester derivatives |
10/15/1992 | CA2407304A1 Human pf4a receptors and their use |
10/14/1992 | EP0508672A2 Fish prolactin |
10/14/1992 | EP0508435A2 Pharmaceutical composition of stabilized [Leu 13]-motilin-Hse |
10/14/1992 | EP0508371A1 Isolation and purification of lantibiotics |
10/14/1992 | EP0508194A1 Stabilized factor VIII preparations |
10/14/1992 | EP0507870A1 Polyhemoglobin stabilized by purine derivatives and glutathione. |
10/14/1992 | EP0507836A1 Novel fibronectin receptor |
10/14/1992 | EP0208743B1 Polydispersed native pseudomonas-flagella (h)-antigens (fag) and methods for their preparation |
10/13/1992 | US5155213 Method for isolating IgAs in the feces |
10/13/1992 | US5155210 Produce localized cytotoxic effects on target cells; antitumor and anticarcinogenic agents |
10/13/1992 | US5155100 Treating cardiovascular disorders in mammals |
10/13/1992 | US5155040 Extracting with alcohol |
10/13/1992 | US5155027 Culturing cells having DNA construct encoding a polypeptide having a nonimmuno- and an immunologlobulin chain which dimerize to become biologically active |
10/13/1992 | CA1308676C Anti-human igg (immunoglobulin g) monoclonal antibody and process for preparing the same |
10/12/1992 | WO1992021700A1 Novel calcitonin, and production and use thereof |
10/12/1992 | CA2065748A1 Isolation and purification of lantibiotics |
10/07/1992 | EP0506963A1 Production of human basic fgf mutein |
10/07/1992 | EP0506944A1 Mechanism based inhibitors of dna methyltransferase |
10/07/1992 | EP0506820A1 Neutrophil chemoattractants |
10/07/1992 | EP0506818A1 Method of covalently bonding proteins to hydrophilic surfaces. |
10/07/1992 | EP0506664A1 Computer graphics for molecular design |
10/07/1992 | EP0213180B1 Neovascularization inhibitors and methods for their production and use |
10/06/1992 | WO1992017503A1 Method for the production of collagen; collagen produced through the method and use of collagen |
10/06/1992 | US5153312 Respiratory system disorders |
10/06/1992 | US5153308 S-sulfonated calcitonin derivatives |
10/06/1992 | US5153173 N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use as immunomodulators and immunoadjuvants |
10/06/1992 | CA2107680A1 Method for the production of collagen; collagen produced through the method and use of collagen |
10/06/1992 | CA1308377C Complex of polyethyleneglycol and tissue plasminogen activator |
10/01/1992 | WO1992017025A2 GnRH ANALOGS |
10/01/1992 | WO1992016631A1 SUCROSE PHOSPHATE SYNTHASE (SPS), ITS PROCESS FOR PREPARATION, ITS cDNA, AND UTILIZATION OF cDNA TO MODIFY THE EXPRESSION OF SPS IN THE PLANT CELLS |
10/01/1992 | WO1992016558A1 Cell surface receptors homologous to coagulation factors v and viii |
10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
10/01/1992 | WO1992016552A1 1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity |
10/01/1992 | WO1992016524A1 Benzo-fused lactams promote release of growth hormone |
10/01/1992 | WO1992016463A1 Polyaspartic acid as a calcium sulfate and a barium sulfate inhibitor |
10/01/1992 | WO1992016300A1 Lipid fractionation |
10/01/1992 | WO1992016292A1 Adsorption matrices |
10/01/1992 | WO1992016232A1 Polysaccharide-protein conjugates |
10/01/1992 | CA2105993A1 Cell surface receptors homologous to coagulation factors v and viii |
09/30/1992 | WO1992017525A1 Polyamino acid superabsorbents |
09/30/1992 | EP0506032A1 Receptor purification method |
09/30/1992 | EP0505954A1 N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity |
09/30/1992 | EP0505908A1 Chimaeric polypeptides |
09/30/1992 | EP0505846A1 Process for converting fused protein into active type human motilin analogues and purifying the analogues |
09/30/1992 | EP0505735A1 Antibiotic A 40926 ester derivatives |
09/30/1992 | EP0505680A1 Octapeptide or heptapeptide derivatives, a process for preparing them as well as medicaments containing these compounds and the use of them |
09/30/1992 | EP0505428A1 Chromogenic substrate. |
09/30/1992 | EP0505385A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety |
09/29/1992 | US5151504 Method for purification of monoclonal antibodies |
09/29/1992 | US5151501 Method for solubilization and naturation of somatotropins utilizing sulfolane |
09/29/1992 | US5151498 Immunomodulators and mitogenic agents by extraction, precipitation and filtration |
09/29/1992 | US5151445 Trypanosoma |
09/29/1992 | US5151433 Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
09/29/1992 | US5151164 Enhanced capillary zone electrophoresis and apparatus for performance thereof |
09/29/1992 | CA2064131A1 Receptor purification method |
09/29/1992 | CA1308217C Substrate peptides |
09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
09/23/1992 | EP0505267A1 Process for chemical modification of proteins |
09/23/1992 | EP0505210A2 Assay for measuring the degradation of type I collagen |
09/23/1992 | EP0505148A1 Stimulating factor of the neu receptor |
09/23/1992 | EP0504751A1 Method for the preparation of interleukin 6 |
09/23/1992 | EP0504363A1 PURIFIED IgG ANTIBODIES |
09/23/1992 | EP0504168A1 Synthetic calcitonin peptides |
09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
09/23/1992 | CN1064684A Insecticidally effective peptides |
09/22/1992 | US5149716 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
09/22/1992 | US5149647 Micrifltration; selective adsorption on strong cation exchange resin; successive and selective elution with saline solutions |
09/22/1992 | CA1307752C Immunoaffinity purification system |
09/21/1992 | CA2063185A1 Benzo-fused lactams that promote the release of growth hormone |
09/20/1992 | CA2063306A1 Process for the chemical modification of proteins |
09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
09/17/1992 | WO1992015887A1 Biosynthetic cerebrospinal fluid control and method of use |
09/17/1992 | WO1992015867A1 Method and device for heterogeneous phase synthesis of macromolecules such as peptides, polynucleotides or oligosaccharides |
09/17/1992 | WO1992015677A1 Process for the development of binding mini-proteins |
09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
09/17/1992 | WO1992015615A1 Serum calcium depressing factor |
09/17/1992 | WO1992015614A1 Method for the stabilization of methionine-containing polypeptides |
09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
09/17/1992 | WO1992015606A1 New inhibitors of endothelial cell proliferation |
09/17/1992 | WO1992015605A2 Inhibitors of human neutrophil elastase and human cathepsin g |
09/17/1992 | WO1992015324A1 Preparation of factor ix |
09/17/1992 | WO1992015316A1 Modified proteins and their use for controlling viral infections |
09/17/1992 | WO1992015195A1 Insecticidally effective peptides |
09/17/1992 | CA2105470A1 Process and apparatus for the heterogenous phase synthesis of macromolecules such as peptides, polynucleotides or oligosaccharides |